相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies
Jonathan J. Lee et al.
MODERN PATHOLOGY (2015)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi
Ryuhei Uchiyama et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors
Allison R. Larson et al.
MODERN PATHOLOGY (2014)
Melanoma epigenetics: novel mechanisms, markers, and medicines
Jonathan J. Lee et al.
LABORATORY INVESTIGATION (2014)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Thomas Wiesner et al.
NATURE COMMUNICATIONS (2014)
Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Klaus G. Griewank et al.
CLINICAL CANCER RESEARCH (2013)
Decreased 5-Hydroxymethylcytosine (5-hmC) is an Independent Poor Prognostic Factor in Gastric Cancer Patients
Qi Yang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma
Maria Colombino et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
BRAF and KIT somatic mutations are present in amelanotic melanoma
Daniela Massi et al.
MELANOMA RESEARCH (2013)
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma
Thilo Gambichler et al.
MELANOMA RESEARCH (2013)
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy
Thomas Botton et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
Low values of 5-hydroxymethylcytosine (5hmC), the sixth base, are associated with anaplasia in human brain tumors
Theo F. J. Kraus et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Elisabetta Fratta et al.
MOLECULAR ONCOLOGY (2011)
TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine
Haikuo Zhang et al.
CELL RESEARCH (2010)
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
Luca Sigalotti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Jill C. Rubinstein et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
Avnish Kapoor et al.
NATURE (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
Conserved role of intragenic DNA methylation in regulating alternative promoters
Alika K. Maunakea et al.
NATURE (2010)
Aberrant DNA methylation in malignant melanoma
Carolina Schinke et al.
MELANOMA RESEARCH (2010)
Human DNA methylomes at base resolution show widespread epigenomic differences
Ryan Lister et al.
NATURE (2009)
分享论文
